LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 108 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $608,225 | -16.3% | 515,445 | 0.0% | 0.00% | – |
| Q2 2023 | $726,777 | -3.1% | 515,445 | -6.6% | 0.00% | – |
| Q1 2022 | $750,000 | +0.7% | 551,993 | +35.6% | 0.00% | – |
| Q4 2021 | $745,000 | -33.8% | 406,930 | -7.8% | 0.00% | – |
| Q3 2021 | $1,126,000 | -12.2% | 441,591 | -1.8% | 0.00% | – |
| Q2 2021 | $1,283,000 | +266.6% | 449,911 | +6.3% | 0.00% | – |
| Q1 2020 | $350,000 | -19.5% | 423,265 | -13.6% | 0.00% | – |
| Q4 2019 | $435,000 | -58.5% | 489,811 | -54.3% | 0.00% | – |
| Q3 2019 | $1,049,000 | – | 1,070,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $41,223,872 | 3.66% |
| Raffles Associates | 1,587,739 | $1,873,532 | 2.48% |
| Defender Capital, LLC. | 5,184,510 | $6,117,722 | 2.22% |
| Prescott General Partners LLC | 1,851,851 | $2,185,184 | 0.14% |
| DCF Advisers, LLC | 82,751 | $97,646 | 0.05% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $63,450 | 0.05% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 781,766 | $922,484 | 0.02% |
| Fort Sheridan Advisors LLC | 83,931 | $99,039 | 0.02% |
| MAI Capital Management | 954,688 | $1,126,532 | 0.02% |
| Piscataqua Savings Bank | 12,499 | $14,623 | 0.01% |